Tumors at stages II–IV express lower levels of SOCS1 mRNA than those of tumors at stage I; additionally, SOCS1 protein is highly expressed in all of the well-differentiated adenocarcinomas (35). Here, SOCS1 is linked to adenocarcinoma.